Nanopharmaceuticals as a solution to neglected diseases: is it possible?

The study of neglected diseases has not received much attention, especially from public and private institutions over the last years, in terms of strong support for developing treatment for these diseases. Support in the form of substantial amounts of private and public investment is greatly needed...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Islan, Germán Abel, Durán, Marcela, Cacicedo, Maximiliano Luis, Nakazato, Gerson, Kobayashi, Renata K. T., Martinez, Diego S. T., Castro, Guillermo Raúl, Durán, Nelson
Formato:	Articulo Preprint
Lenguaje:	Inglés
Publicado:	2017
Materias:	Química Liposomes Nanobiotechnology Nanoemulsions Nanoparticles Neglected diseases Solid lipid nanoparticles
Acceso en línea:	http://sedici.unlp.edu.ar/handle/10915/100518 https://ri.conicet.gov.ar/11336/49424
Aporte de:	SEDICI (UNLP) de Universidad Nacional de La Plata

id	I19-R120-10915-100518
record_format	dspace
institution	Universidad Nacional de La Plata
institution_str	I-19
repository_str	R-120
collection	SEDICI (UNLP)
language	Inglés
topic	Química Liposomes Nanobiotechnology Nanoemulsions Nanoparticles Neglected diseases Solid lipid nanoparticles
spellingShingle	Química Liposomes Nanobiotechnology Nanoemulsions Nanoparticles Neglected diseases Solid lipid nanoparticles Islan, Germán Abel Durán, Marcela Cacicedo, Maximiliano Luis Nakazato, Gerson Kobayashi, Renata K. T. Martinez, Diego S. T. Castro, Guillermo Raúl Durán, Nelson Nanopharmaceuticals as a solution to neglected diseases: is it possible?
topic_facet	Química Liposomes Nanobiotechnology Nanoemulsions Nanoparticles Neglected diseases Solid lipid nanoparticles
description	The study of neglected diseases has not received much attention, especially from public and private institutions over the last years, in terms of strong support for developing treatment for these diseases. Support in the form of substantial amounts of private and public investment is greatly needed in this area. Due to the lack of novel drugs for these diseases, nanobiotechnology has appeared as an important new breakthrough for the treatment of neglected diseases. Recently, very few reviews focusing on filiarasis, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, trypanosomiasis, and tuberculosis, and dengue virus have been published. New developments in nanocarriers have made promising advances in the treatment of several kinds of diseases with less toxicity, high efficacy and improved bioavailability of drugs with extended release and fewer applications. This review deals with the current status of nanobiotechnology in the treatment of neglected diseases and highlights how it provides key tools for exploring new perspectives in the treatment of a wide range of diseases.
format	Articulo Preprint
author	Islan, Germán Abel Durán, Marcela Cacicedo, Maximiliano Luis Nakazato, Gerson Kobayashi, Renata K. T. Martinez, Diego S. T. Castro, Guillermo Raúl Durán, Nelson
author_facet	Islan, Germán Abel Durán, Marcela Cacicedo, Maximiliano Luis Nakazato, Gerson Kobayashi, Renata K. T. Martinez, Diego S. T. Castro, Guillermo Raúl Durán, Nelson
author_sort	Islan, Germán Abel
title	Nanopharmaceuticals as a solution to neglected diseases: is it possible?
title_short	Nanopharmaceuticals as a solution to neglected diseases: is it possible?
title_full	Nanopharmaceuticals as a solution to neglected diseases: is it possible?
title_fullStr	Nanopharmaceuticals as a solution to neglected diseases: is it possible?
title_full_unstemmed	Nanopharmaceuticals as a solution to neglected diseases: is it possible?
title_sort	nanopharmaceuticals as a solution to neglected diseases: is it possible?
publishDate	2017
url	http://sedici.unlp.edu.ar/handle/10915/100518 https://ri.conicet.gov.ar/11336/49424
work_keys_str_mv	AT islangermanabel nanopharmaceuticalsasasolutiontoneglecteddiseasesisitpossible AT duranmarcela nanopharmaceuticalsasasolutiontoneglecteddiseasesisitpossible AT cacicedomaximilianoluis nanopharmaceuticalsasasolutiontoneglecteddiseasesisitpossible AT nakazatogerson nanopharmaceuticalsasasolutiontoneglecteddiseasesisitpossible AT kobayashirenatakt nanopharmaceuticalsasasolutiontoneglecteddiseasesisitpossible AT martinezdiegost nanopharmaceuticalsasasolutiontoneglecteddiseasesisitpossible AT castroguillermoraul nanopharmaceuticalsasasolutiontoneglecteddiseasesisitpossible AT durannelson nanopharmaceuticalsasasolutiontoneglecteddiseasesisitpossible
bdutipo_str	Repositorios
_version_	1764820440476286979

Nanopharmaceuticals as a solution to neglected diseases: is it possible?

Ejemplares similares